REC.MI - Recordati Industria Chimica e Farmaceutica S.p.A.

Milan - Milan Delayed Price. Currency in EUR

Recordati Industria Chimica e Farmaceutica S.p.A.

Via Matteo Civitali 1
Milan, MI 20148
39 02 487871

IndustryDrug Manufacturers - Major
Full Time Employees4,100

Key Executives

NameTitlePayExercisedYear Born
Mr. Andrea RecordatiCEO & DirectorN/AN/A1971
Mr. Fritz SquindoCFO, MD & Exec. DirectorN/AN/A1956
Ms. Marianne TatschkeDirector of Investor Relations & Corp. CommunicationsN/AN/AN/A
Ms. Daria GhidoniVP of Corp. Legal CounselN/AN/AN/A
Mr. Gabriele FinziVP of Corp. Devel. & LicensingN/AN/AN/A
Amounts are as of December 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals in Europe, the Middle East, Africa, the United States, Canada, and internationally. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, cosmetics, dermatology, dietary supplements, gynecology and obstetrics, medical devices, musculo-skeletal disorders and analgesia, over the counter/non-prescription pharmaceuticals, urology, allergy, anti-infectives, central nervous system, endocrinology, gastrointestinal, nutrition and related products, immune-suppressants, pain management/inflammation, generics, pneumology, antipyretics and cold preparations, endocrinology, oncology, respiratory, and radio contrast agent, as well as ear, nose, and throat. It also provides pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy.

Corporate Governance

Recordati Industria Chimica e Farmaceutica S.p.A.’s ISS Governance QualityScore as of July 29, 2019 is 8. The pillar scores are Audit: 5; Board: 7; Shareholder Rights: 1; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.